BioRestorative Therapies

Mandy Clyde

Vice President of Operations

Phone: (561) 904-6070

Email: mclyde@biorestorative.com
http://www.biorestorative.com/content/investor-contacts  

Jeff Ramson

Phone: (646) 863-6893

Email: jramson@proactivecapital.com
http://www.biorestorative.com/content/investor-contacts  

http://www.biorestorative.com/content/events-and-presentations GrB  

http://www.biorestorative.com/content/corporate-governance GrB  

- 8-K (Filed: 06-06-2014)
Close Window
Sub Document 1
Page 1: (cont'd)
Page 2: (cont'd)
Page 3: (cont'd)

Copyright © 2014 QuoteMedia. All rights reserved. Terms of Use.
Market Data powered by QuoteMedia, www.quotemedia.com, SEC filings by Morningstar.
http://app.quotemedia.com/quotetools/...?ipage=9643703&xbrl=false  

http://www.biorestorative.com/content/sec-filings GrB  

Last Price 0,30  
Last Trade 06/20/14  
Change
% Change 0.00%  
Volume 117,32k
Open 0,299
High 0,323
Low 0,289
52 Week Low 0,2801
52 Week High 1,05
http://www.biorestorative.com/content/stock-information  

http://www.biorestorative.com/content/news GrB  

http://www.biorestorative.com/content/news GrB  

is developing medical procedures using cell and tissue protocols, primarily involving adult stem cells (non-embryonic), designed for patients to undergo minimally invasive cellular-based treatments.http://www.biorestorative.com/content/company-information
 

Our brtxDISC™ Program (Disc Implanted Stem Cells) is designed to offer a non-surgical treatment for the potential cure and relief of bulging and herniated discs by providing an alternative treatment for damaged discs - representing a much needed therapy and offering a potential solution to the large population of back pain sufferers by addressing the gap between non-invasive and invasive procedures.
Our ThermoStem® Program (Brown Fat Stem Cells) focuses on treatments for metabolic disorders (diabetes, heart disease, etc.) and obesity by using brown fat stem cells. Initial research indicates increased caloric burning (weight loss) and reduced glucose and lipid levels in the body.
Our brtx-C Cosmetic Program is based on the development of a human cellular extract that, per initial in vitro studies, when applied to human skin cells, appears to cause an increase in the production of collagen and fibronectin, which are proteins that are essentail to combating the aging of skin.  Potential cosmetic uses are being explored with third parties.
Our Stem Pearls® Brand offers plant stem cell-based cosmetic skincare products – visit us to learn more or make a purchase at http://www.stempearls.com.http://...e.com/content/company-information  

www.biorestorative.com


buran und MfG  

buran: nur ein börsenboard geführt von www.bundesbank.de 21:18 #1
achte er einfach auf die links
Mit freundlichen Grüssen Mario Meierhof 39517 Lüderitz Gartenstrasse 6
mariomeierhof@web.de
Tel.:039361/96548 Atelier Meierhof 039361/51273 Kuhle
gez MARIO alias buran http://www.ariva.de/…/nur-ein-boersenboard-gefuehrt-von-www…

Deutsche Bundesbank - Startseite
Die Deutsche Bundesbank ist die Zentralbank der Bundesrepublik Deutschland. Zentrales Geschäftsfeld ist die Geldpolitik des Eurosystems.
BUNDESBANK.DE
https://www.facebook.com/mario.meierhof  

Kosmonova buran  

Bitcoin (BTC) ist eine anonyme Online-Währung. Sie wird durch verschiedene rechenintensive, kryptographische Algorithmen von den Benutzern generiert ("Mining"). http://www.ariva.de/extras/lexikon.m?begriff=Bitcoin
 

Börsenbucheinsicht
http://www.ariva.de/...e_therapies-aktie/times_and_sales?boerse_id=83 GrB  

Zeit     Kurs Stück
  17:55:30§0,44 $ 400
  15:33:59§0,45 $ 4.400
____________________
GRATULATION  

..yöah  

::::::::: 0,4398 $ ,GrB  

:::::::::::::::: 0,4299 $ +2,24% +0,0094 $
In Euro: 0,3834 € | Nasdaq OTC Other, 08.05.15 ,GrB  

::::::::::: 3,55 $ 0,00% +0,00 $
In Euro: 3,1914 € | 29.06.16 Nasdaq OTC Other ,GrB  

– BioRestorative Therapies, Inc. ("BRT" or the “Company") (BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has received clearance by the U.S. Food and Drug Administration (FDA) to commence a Phase 2 clinical trial using its lead cell therapy candidate, BRTX-100, to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs. http://www.biorestorative.com/content/...e-2-clinical-trial-treatment

 

::::::::::::::::::::: 2,90 $ +1,75% +0,05 $
In Euro: 2,5290 € | 14.07.17 Nasdaq OTC Other ,GrB  

.
..knicken Sie es ..kein Arbeiten so ..SPAM Filter raus ..DANKE